Skip to main content
Year archive

Galapagos NV — 2011 filings

All 124 regulatory filings released by Galapagos NV (GLPG) in 2011, sourced directly from the official regulator.

124 Filings
2011 Period
2011 filings (124)
Filing Released Lang
Galapagos start Fase I studie van kandidaat-medicijn GLPG0974
Legal Proceedings Report
2011-12-21 Dutch
Galapagos initiates clinical study with GLPG0974, the first anti-inflammatory candidate drug targeting GPR43
Regulatory Filings
2011-12-21 English
Galapagos start Fase I studie van kandidaat-medicijn GLPG0974
Legal Proceedings Report
2011-12-21 Dutch
Galapagos verhoogt aandelenkapitaal door uitoefenen van warrants
Share Issue/Capital Change
2011-12-19 Dutch
Galapagos kandidaat-medicijn in GSK alliantie bereikt mijlpaal voor klinische effectiviteit
Regulatory Filings
2011-12-19 Dutch
Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance
Regulatory Filings
2011-12-19 English
Galapagos kandidaat-medicijn in GSK alliantie bereikt mijlpaal voor klinische effectiviteit
Earnings Release FY 2011
2011-12-19 Dutch
Galapagos ontvangt succesbetaling van €4 miljoen in artrose alliantie met Servier
Earnings Release FY 2011
2011-12-15 Dutch
Galapagos receives €4 million in milestones from Servier in their osteoarthritis alliance
Regulatory Filings
2011-12-15 English
Galapagos ontvangt succesbetaling van €4 miljoen in artrose alliantie met Servier
M&A Activity
2011-12-15 Dutch
Kandidaat-medicijn GLP0634 van Galapagos laat uitstekende werking en veiligheid zien in Fase II reuma studie
Earnings Release FY 2011
2011-11-22 Dutch
Galapagos’ GLPG0634 shows excellent efficacy and safety in rheumatoid arthritis Phase II study
Earnings Release FY 2011
2011-11-22 English
Kandidaat-medicijn GLP0634 van Galapagos laat uitstekende werking en veiligheid zien in Fase II reuma studie
Earnings Release FY 2011
2011-11-22 Dutch
Galapagos business update
Earnings Release 9M 2011
2011-11-10 English
3Q2011update_FINAL.pdf
Earnings Release 9M 2011
2011-11-10 English
3Q2011update_final_NL.pdf
Earnings Release 9M 2011
2011-11-10 Dutch
Galapagos gaat resultaten bekend maken met selectieve JAK1 remmer in reuma patiënten op 22 november 2011
Regulatory Filings
2011-11-07 Dutch
Galapagos gaat resultaten bekend maken met selectieve JAK1 remmer in reuma patiënten op 22 november 2011
Regulatory Filings
2011-11-07 Dutch
Galapagos wint 2011 Scrip Award voor “Biotech Bedrijf van het Jaar”
Regulatory Filings
2011-11-04 Dutch
Galapagos wint 2011 Scrip Award voor “Biotech Bedrijf van het Jaar”
Regulatory Filings
2011-11-04 Dutch
Galapagos breidt samenwerking met Chiesi nogmaals uit
Regulatory Filings
2011-10-12 Dutch
Galapagos announces second extension to services collaboration with Chiesi
M&A Activity
2011-10-12 English
Galapagos breidt samenwerking met Chiesi nogmaals uit
Regulatory Filings
2011-10-12 Dutch
Servier en Galapagos gaan alliantie aan voor innovatieve behandeling van kanker
Capital/Financing Update
2011-10-03 Dutch
Servier and Galapagos initiate strategic alliance for innovative treatments in oncology
Regulatory Filings
2011-10-03 English
Servier en Galapagos gaan alliantie aan voor innovatieve behandeling van kanker
Capital/Financing Update
2011-10-03 Dutch
Galapagos and Genentech extend drug discovery collaboration
Regulatory Filings
2011-08-18 English
Galapagos verlengt samenwerking met Genentech
Regulatory Filings
2011-08-18 Dutch
Galapagos maakt halfjaar cijfers 2011 bekend
Interim / Quarterly Report H1 2011
2011-08-05 Dutch
Galapagos announces half year results 2011
Interim / Quarterly Report H1 2011
2011-08-05 English
Galapagos maakt halfjaar cijfers 2011 bekend
Interim / Quarterly Report H1 2011
2011-08-05 Dutch
Halfjaarverslag_2011_FINAL.pdf
Interim / Quarterly Report H1 2011
2011-08-05 Dutch
Interim Report_2011_FINAL.pdf
Interim / Quarterly Report H1 2011
2011-08-05 English
Galapagos start tweede Fase I studie van kandidaat-medicijn GLPG0492 tegen cachexia
Regulatory Filings
2011-07-20 Dutch
Galapagos initiates Proof-of-Mechanism clinical study for candidate cachexia drug GLPG0492
Regulatory Filings
2011-07-20 English
Galapagos start tweede Fase I studie van kandidaat-medicijn GLPG0492 tegen cachexia
Regulatory Filings
2011-07-20 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2011-07-01 English
Galapagos verhoogt aandelenkapitaal door uitoefenen van warrants
Share Issue/Capital Change
2011-07-01 Dutch
Galapagos start Fase II reuma-onderzoek met GLPG0634
Investor Presentation
2011-06-09 Dutch
Galapagos initiates Phase II trial for GLPG0634
Regulatory Filings
2011-06-09 English
Galapagos start Fase II reuma-onderzoek met GLPG0634
Investor Presentation
2011-06-09 Dutch
Evotec neemt compound management business van Galapagos over
M&A Activity
2011-06-01 Dutch
Evotec acquires compound management business from Galapagos
M&A Activity
2011-06-01 English
Evotec neemt compound management business van Galapagos over
M&A Activity
2011-06-01 Dutch
Ronald Brus treedt af als Lid Raad van Bestuur van Galapagos
Board/Management Information
2011-05-31 Dutch
Galapagos kondigt de goedkeuring aan van alle voorstellen van de BAV; creëert nieuwe warrantplannen
Share Issue/Capital Change
2011-05-24 Dutch
Galapagos announces approval of all EGM proposals; creates new warrant plans
Capital/Financing Update
2011-05-23 English
Galapagos kondigt de goedkeuring aan van alle voorstellen van de BAV; creëert nieuwe warrantplannen
Share Issue/Capital Change
2011-05-23 Dutch
Galapagos business update
Earnings Release Q1 2011
2011-05-13 English
1Q2011update_FINAL.pdf
Earnings Release Q1 2011
2011-05-13 English
1Q2011update_FINAL_NL.pdf
Regulatory Filings
2011-05-13 Dutch
trans notice 12 May 2011_FINAL.pdf
Major Shareholding Notification
2011-05-12 English
NL trans notice 12 May 2011_FINAL.pdf
Major Shareholding Notification
2011-05-12 Dutch
Galapagos start tweede klinische studie naar werking van kandidaat-medicijn met GlaxoSmithKline
Regulatory Filings
2011-05-11 Dutch
Galapagos initiates second Proof of Mechanism clinical study
Regulatory Filings
2011-05-11 English
Galapagos start tweede klinische studie naar werking van kandidaat-medicijn met GlaxoSmithKline
Regulatory Filings
2011-05-11 Dutch
Bijzonder Verslag RvB per art 596-598 WVenn re Warrantplan 2011 (B) (web).pdf
Capital/Financing Update
2011-05-03 Dutch
Statutory Auditor Report per art 596-598 BCC re Warrant Plan 2011 (B).pdf
Audit Report / Information FY 2011
2011-05-03 English
Bijzonder Verslag RvB per art 583 WVenn re Warrantplan 2011 (B) (web).pdf
Share Issue/Capital Change
2011-05-03 Dutch
Special Board Report per art 604 BCC re Authorized capital (web).pdf
Capital/Financing Update
2011-05-03 English
Bijzonder Verslag RvB per art 604 WVenn re Toegestaan Kapitaal (web).pdf
Capital/Financing Update
2011-05-03 Dutch
Special Board Report per art 596-598 BCC re Warrant Plan 2011 (B) (web).pdf
Remuneration Information
2011-05-03 English
Commissarisverslag per art 596-598 WVenn re Warrantplan 2011 (B).pdf
Share Issue/Capital Change
2011-05-03 Dutch
Special Board Report per art 583 BCC re Warrant Plan 2011 (B) (web).pdf
Capital/Financing Update
2011-05-03 English
Galapagos, Volmacht BAV - Proxy EGM 23 May 2011.pdf
Proxy Solicitation & Information Statement
2011-05-03 Dutch
Galapagos EGM 23 May 2011, convocation E.pdf
AGM Information
2011-05-03 English
Galapagos BAV 23 mei 2011, oproeping NL.pdf
AGM Information
2011-05-03 Dutch
Galapagos levert oncologie targets aan Janssen
Earnings Release FY 2011
2011-04-20 Dutch
Galapagos delivers validated oncology targets to Janssen
Regulatory Filings
2011-04-20 English
Galapagos levert oncologie targets aan Janssen
Earnings Release FY 2011
2011-04-20 Dutch
Galapagos stopt Fase II studie met GLPG0259 en richt zich op haar andere reuma programma’s
Regulatory Filings
2011-04-15 Dutch
Galapagos discontinues Phase II trial for GLPG0259, focuses resources on other rheumatoid arthritis programs
Regulatory Filings
2011-04-15 English
Galapagos stopt Fase II studie met GLPG0259 en richt zich op haar andere reuma programma’s
Regulatory Filings
2011-04-15 Dutch
Galapagos Annual Financial Report 2010.pdf
Annual Report FY 2010
2011-04-11 English
Galapagos Jaarlijks Financieel Verslag 2010.pdf
Annual Report FY 2010
2011-04-11 Dutch
Dr Vicki Sato voorgedragen voor Raad van Bestuur van Galapagos
Board/Management Information
2011-04-01 Dutch
Dr Vicki Sato to be appointed to Galapagos’ Board of Directors
Board/Management Information
2011-04-01 English
Dr Vicki Sato voorgedragen voor Raad van Bestuur van Galapagos
Board/Management Information
2011-04-01 Dutch
Commissarisverslag per art 596-598 WVenn re Warrantplan 2011 (B).pdf
Audit Report / Information FY 2011
2011-04-01 Dutch
Special Board Report per art 604 BCC re Authorized capital (web).pdf
Capital/Financing Update
2011-04-01 English
Bijzonder Verslag RvB per art 604 WVenn re Toegestaan Kapitaal (web).pdf
Capital/Financing Update
2011-04-01 Dutch
Special Board Report per art 596-598 BCC re Warrant Plan 2011 (B) (web).pdf
Share Issue/Capital Change
2011-04-01 English
Bijzonder Verslag RvB per art 596-598 WVenn re Warrantplan 2011 (B) (web).pdf
Capital/Financing Update
2011-04-01 Dutch
Special Board Report per art 583 BCC re Warrant Plan 2011 (B) (web).pdf
Capital/Financing Update
2011-04-01 English
Bijzonder Verslag RvB per art 583 WVenn re Warrantplan 2011 (B) (web).pdf
Share Issue/Capital Change
2011-04-01 Dutch
Statutory Auditor Report, Non-consolidated Accounts per 31-12-2010.pdf
Audit Report / Information FY 2010
2011-04-01 English
Statutory Auditor Report, Consolidated Accounts, per 31-12-2010.pdf
Audit Report / Information FY 2010
2011-04-01 English
Galapagos NV, Statutaire jaarrekening (niet geconsolideerd) per 31-12-2010 (only in Dutch).pdf
Annual Report FY 2010
2011-04-01 Dutch
Galapagos NV, Statutaire jaarrekening (niet geconsolideerd) per 31-12-2010.pdf
Annual Report FY 2010
2011-04-01 Dutch
Commissarisverslag, Statutaire Jaarrekening per 31-12-2010.pdf
Audit Report / Information FY 2010
2011-04-01 Dutch
Commissarisverslag, Geconsolideerde Jaarrekening per 31-12-2010.pdf
Audit Report / Information FY 2010
2011-04-01 Dutch
Statutory Auditor Report per art 596-598 BCC re Warrant Plan 2011 (B).pdf
Share Issue/Capital Change
2011-04-01 English
110328 AGM-EGM 26 April 2011 convocation E final.pdf
AGM Information
2011-04-01 French
110331 AGM-EGM 26 April 2011, oproeping NL, finaal.pdf
AGM Information
2011-04-01 Dutch
Galapagos verhoogt aandelenkapitaal door uitoefenen van warrants
Share Issue/Capital Change
2011-03-31 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2011-03-30 English
Galapagos verhoogt aandelenkapitaal door uitoefenen van warrants
Share Issue/Capital Change
2011-03-30 Dutch
share capital increase_30Mar2011 FINAL.pdf
Share Issue/Capital Change
2011-03-30 English
share capital increase_30 march 2011_NL FINAL.pdf
Share Issue/Capital Change
2011-03-30 Dutch
Galapagos start Fase Ib klinische studie bij kankerpatiënten
Legal Proceedings Report
2011-03-14 Dutch
Galapagos starts Phase Ib clinical study in cancer patients
Regulatory Filings
2011-03-14 English
Galapagos start Fase Ib klinische studie bij kankerpatiënten
Regulatory Filings
2011-03-14 Dutch
Galapagos behaalt recordomzet en vergroot winstgevendheid in 2010
Earnings Release FY 2010
2011-03-04 Dutch
FY2010_4MAR2011_PR.pdf
Earnings Release FY 2010
2011-03-04 English
FY2010_4MAR2011_NL.pdf
Earnings Release FY 2010
2011-03-04 Dutch
Galapagos levert kandidaat-medicijn in GSK alliantie, ontvangt €6,7 miljoen
Regulatory Filings
2011-03-02 Dutch
Galapagos delivers candidate drug in GSK alliance, receives €6.7 million
Capital/Financing Update
2011-03-02 English
Galapagos levert kandidaat-medicijn in GSK alliantie, ontvangt €6,7 miljoen
Regulatory Filings
2011-03-02 Dutch
Galapagos ontvangt succesbetaling van €4 miljoen van Servier
Earnings Release FY 2010
2011-02-08 Dutch
Galapagos creëert nieuw warrantplan
Remuneration Information
2011-02-08 Dutch
Galapagos receives €4 million in milestones from Servier
Regulatory Filings
2011-02-08 English
Galapagos ontvangt succesbetaling van €4 miljoen van Servier
Earnings Release FY 2010
2011-02-08 Dutch
Galapagos krijgt €2,7 miljoen subsidie voor antivirale medicijnontwikkeling
Regulatory Filings
2011-02-07 Dutch
Galapagos receives €2.7 million grant for antiviral drug discovery
Regulatory Filings
2011-02-07 English
Galapagos krijgt €2,7 miljoen subsidie voor antivirale medicijnontwikkeling
Regulatory Filings
2011-02-07 Dutch
Galapagos behaalt omzet van €137 miljoen in 2010, verwacht sterk 2011
Earnings Release FY 2010
2011-02-04 Dutch
Galapagos en Merck & Co. komen overeen allianties te beëindigen
Regulatory Filings
2011-02-04 Dutch
Galapagos and Merck & Co., Inc. agree to end strategic alliances
Regulatory Filings
2011-02-04 English
Galapagos en Merck & Co. komen overeen allianties te beëindigen
Regulatory Filings
2011-02-04 Dutch
Galapagos achieves €137 million revenues in 2010, outlook for continued strong 2011 performance
Earnings Release FY 2010
2011-02-04 English
Galapagos behaalt omzet van €137 miljoen in 2010, verwacht sterk 2011
Earnings Release FY 2010
2011-02-04 Dutch
Galapagos ontvangt succesbetaling van €7,4 miljoen in artritis alliantie met GlaxoSmithKline
Regulatory Filings
2011-01-12 Dutch
Galapagos receives €7.4 M milestone in arthritis alliance with GlaxoSmithKline
Earnings Release FY 2010
2011-01-11 English
Galapagos ontvangt succesbetaling van €7,4 miljoen in artritis alliantie met GlaxoSmithKline
Regulatory Filings
2011-01-11 Dutch